To recapitulate the early transformational events and the stochastic nature of early breast cancer development, we generated a controllable in vitro model system by stably transducing a doxycycline-inducible HER2 construct in MCF10A cells (Carter et al., 2017). Here, ERBB2 is linked to breast cancer.